Dr. Reysla Maria da Silveira Mariano is a Ph.D. Researcher in the Laboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte (MG), Brazil. She received her Bachelor’s degree in Biochemistry from Universidade
Federal de São João del-Rei in 2010–2014, and her Ph.D. degree in Biochemistry
and Molecular Biology from Universidade Federal de São João del-Rei in
2015–2019. She has been a researcher at Vet Solutions and a Postdoctoral
Research Fellow at the University of Minas Gerais since 2019. Since 2023, she
has been a Researcher at the FAPESP Innovative Research in Small Businesses
Program—PIPE, working on the project Development of a new immunobiological against
Visceral Leishmaniasis at Vet Solutions. She is currently seeking research
opportunities. Her main areas of expertise are maximization of recombinant
protein production, diagnosis of neglected diseases, immunoassay optimization
to market standards, the identification of epitopes for diagnosis (bioinformatics),
animal research, statistic analyses and data interpretation, and scientific
communication.
Dr. Reysla Maria da Silveira Mariano is a Ph.D. Researcher in the Laboratory of Biology of Cell Interactions, Department of Morphology, Federal University of Minas Gerais (UFMG), Belo Horizonte (MG), Brazil. She received her Bachelor’s degree in Biochemistry from Universidade
Federal de São João del-Rei in 2010–2014, and her Ph.D. degree in Biochemistry
and Molecular Biology from Universidade Federal de São João del-Rei in
2015–2019. She has been a researcher at Vet Solutions and a Postdoctoral
Research Fellow at the University of Minas Gerais since 2019. Since 2023, she
has been a Researcher at the FAPESP Innovative Research in Small Businesses
Program—PIPE, working on the project Development of a new immunobiological against
Visceral Leishmaniasis at Vet Solutions. She is currently seeking research
opportunities. Her main areas of expertise are maximization of recombinant
protein production, diagnosis of neglected diseases, immunoassay optimization
to market standards, the identification of epitopes for diagnosis (bioinformatics),
animal research, statistic analyses and data interpretation, and scientific
communication.